Search Results - "Douglas, D.D"

Revision Hip Arthroplasty Using a Modular Revision Hip System in Cases of Severe Bone Loss by Dzaja, Ivan, MD, Lyons, Matt C., MBBS, McCalden, Richard W., MD, MPhil, (Edin), FRCSC, Naudie, Douglas D.D., MD, FRCSC, Howard, James L., MD, MSc, FRCSC

“…Abstract We sought to identify outcomes of the Restoration Modular Hip System in cases of severe femoral bone stock deficiency. We performed a retrospective…”
Get full text

227 MAGNETIC RESONANCE ELASTOGRAPHY (MRE) CAN DISCRIMINATE NORMAL VS. ABNORMAL LIVER BIOPSY IN CANDIDATES FOR LIVE LIVER DONATION by Gallegos-Orozco, J.F, Silva, A.M, Chang, Y.-H, Batheja, M.J, Hansen, K.L, Dora, L.-H, De Petris, G, Carey, E.J, Aqel, B.A, Byrne, T.J, Douglas, D.D, Mulligan, D.C, Rakela, J, Silva, A, Vargas, H.E

Get full text

498 NATURAL HISTORY OF HEPATITIS C AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE by Yosephy, A, Gallegos-Orozco, J.F, Byrne, T.J, Noble, B, Aqel, B, Carey, E, Douglas, D.D, Mulligan, D, Rakela, J, Vargas, H.E

Get full text

Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area by Blair, J.E., Douglas, D.D., Mulligan, D.C.

“…: Coccidioidomycosis (CM) is an endemic fungal infection of the desert southwestern United States. In immunocompromised hosts, such as transplant recipients,…”
Get full text

The effect of orthotopic liver transplantation on the QTc interval in patients with end-stage liver disease by Carey, E.J, Mulligan, David C, Balan, Vijayan, Harrison, M.Edwyn, Rakela, Jorge, Douglas, D.D

Get full text

The effect of orthotopic liver transplantation on the QTc interval in patients with end-stage liver disease by Carey, E.J., Mulligan, David C., Balan, Vijayan, Harrison, M. Edwyn, Rakela, Jorge, Douglas, D.D.

Get full text

Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers by Douglas, D D, Taswell, H F, Rakela, J, Rabe, D

“…A recent study in hepatitis B surface antigen (HBsAg)-negative, antibody to hepatitis B core antigen (anti-HBc)-positive blood donors from a population with a…”
Get more information